CompletedNot Applicable

Comparative Effectiveness Trial for Diagnosis of Necrotizing Enterocolitis

United States169 participantsStarted 2022-11-01

Plain-language summary

The overall objective of our study is to determine the clinical usefulness of BUS for NEC evaluation in diverse NICU settings.

Who can participate

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Admitted to the NICU at CMKC or KUMC * With clinical suspicion for NEC for which further imaging evaluation was decided by treating neonatologist Exclusion Criteria • Infants with major gastrointestinal anomalies such as gastroschisis or omphalocele that prevent BUS from being performed

What they're measuring

Days to Full Enteral Feeds: Extended Rule Out Group

Timeframe: Within 30 days of NEC concern

Days to Full Enteral Feeds: Quick Rule Out Group

Timeframe: Within 30 days of NEC concern

Days to Full Enteral Feeds: NEC Ruled In

Timeframe: Within 30 days of NEC concern

Trial details

NCT IDNCT05573113

SponsorChildren's Mercy Hospital Kansas City

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-23

Results submitted2025-09-18

View on ClinicalTrials.gov More Necrotizing Enterocolitis trials